Skip to main content
logo
Alivus Life Sciences Limited (NSE:ALIVUS)
India flag India · Delayed Price · Currency is INR
1,048.00
-7.50 (-0.71%)
Jun 1, 2026, 3:30 PM IST

Alivus Life Sciences Revenue

In the fiscal year ending March 31, 2026, Alivus Life Sciences had annual revenue of 25.52B INR with 6.91% growth. Alivus Life Sciences had revenue of 6.89B in the quarter ending March 31, 2026, with 6.09% growth.

Revenue
25.52B
Revenue Growth
+6.91%
P/S Ratio
5.08
Revenue / Employee
11.58M
Employees
2,203
Market Cap
129.55B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202625.52B1.65B6.91%
Mar 31, 202523.87B1.04B4.54%
Mar 31, 202422.83B1.22B5.64%
Mar 31, 202321.61B380.06M1.79%
Mar 31, 202221.23B2.38B12.63%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Emcure Pharmaceuticals92.04B
Piramal Pharma88.69B
Alembic Pharmaceuticals73.45B
Strides Pharma Science48.59B
Akums Drugs and Pharmaceuticals43.59B
NATCO Pharma40.78B
Eris Lifesciences31.15B
Cohance Lifesciences22.69B
Revenue Rankings

Alivus Life Sciences News

More News